학술논문
Kinase inhibitors for advanced medullary thyroid carcinoma
Document Type
article
Author
Source
Clinics. January 2012 67(1)
Subject
Language
English
ISSN
1807-5932
Abstract
The recent availability of molecular targeted therapies leads to a reconsideration of the treatment strategy for patients with distant metastases from medullary thyroid carcinoma. In patients with progressive disease, treatment with kinase inhibitors should be offered.